1. Home
  2. SUPN vs RNW Comparison

SUPN vs RNW Comparison

Compare SUPN & RNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$45.59

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo ReNew Energy Global plc

RNW

ReNew Energy Global plc

HOLD

Current Price

$7.58

Market Cap

2.7B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
RNW
Founded
2005
2011
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.7B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
SUPN
RNW
Price
$45.59
$7.58
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$63.25
$7.83
AVG Volume (30 Days)
1.1M
1.1M
Earning Date
11-04-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
413.66
EPS
N/A
0.26
Revenue
$681,539,000.00
$1,382,164,625.00
Revenue This Year
$8.29
N/A
Revenue Next Year
$22.72
$16.58
P/E Ratio
N/A
$29.09
Revenue Growth
4.54
46.76
52 Week Low
$29.16
$5.42
52 Week High
$57.65
$8.24

Technical Indicators

Market Signals
Indicator
SUPN
RNW
Relative Strength Index (RSI) 43.24 53.00
Support Level $44.37 $7.22
Resistance Level $47.00 $7.64
Average True Range (ATR) 1.56 0.12
MACD -0.02 0.03
Stochastic Oscillator 55.51 86.90

Price Performance

Historical Comparison
SUPN
RNW

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

Share on Social Networks: